Kirk Allen Coleman is Chief Financial Officer of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 45,859 shares of TFFP, which is worth approximately $2,751. The most recent transaction as insider was on Jul 03, 2024, when has been sold 10,184 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.9K
0% 3M change
28.55% 12M change
Total Value Held $2,751

KIRK ALLEN COLEMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2024
BUY
Grant, award, or other acquisition
-
10,184 Added 18.17%
45,859 Common Stock
Aug 15 2023
BUY
Open market or private purchase
$5,000 $0.25 p/Share
20,000 Added 35.92%
35,675 Common Stock
Mar 10 2023
BUY
Open market or private purchase
$9,480 $0.79 p/Share
12,000 Added 43.36%
15,675 Common Stock
May 17 2022
BUY
Open market or private purchase
$2,053 $4.83 p/Share
425 Added 10.37%
3,675 Common Stock
May 16 2022
BUY
Open market or private purchase
$5,500 $4.4 p/Share
1,250 Added 27.78%
3,250 Common Stock
Sep 16 2021
BUY
Open market or private purchase
$7,300 $7.3 p/Share
1,000 Added 33.33%
2,000 Common Stock
Mar 15 2021
SELL
Open market or private sale
$85,250 $17.05 p/Share
5,000 Reduced 83.33%
1,000 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$12,500 $2.5 p/Share
5,000 Added 45.45%
6,000 Common Stock
Feb 16 2021
SELL
Open market or private sale
$84,100 $16.82 p/Share
5,000 Reduced 83.33%
1,000 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$12,500 $2.5 p/Share
5,000 Added 45.45%
6,000 Common Stock
Jan 15 2021
SELL
Open market or private sale
$87,500 $17.5 p/Share
5,000 Reduced 83.33%
1,000 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$12,500 $2.5 p/Share
5,000 Added 45.45%
6,000 Common Stock
Dec 23 2020
SELL
Open market or private sale
$152,400 $15.24 p/Share
10,000 Reduced 90.91%
1,000 Common Stock
Dec 23 2020
BUY
Exercise of conversion of derivative security
$25,000 $2.5 p/Share
10,000 Added 47.62%
11,000 Common Stock
Nov 10 2020
SELL
Open market or private sale
$226,800 $15.12 p/Share
15,000 Reduced 93.75%
1,000 Common Stock
Nov 10 2020
BUY
Exercise of conversion of derivative security
$37,500 $2.5 p/Share
15,000 Added 48.39%
16,000 Common Stock
KAC

Kirk Allen Coleman

Chief Financial Officer
Austin, TX

Track Institutional and Insider Activities on TFFP

Follow TFF Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFFP shares.

Notify only if

Insider Trading

Get notified when an Tff Pharmaceuticals, Inc. insider buys or sells TFFP shares.

Notify only if

News

Receive news related to TFF Pharmaceuticals, Inc.

Track Activities on TFFP